Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if rBet v1-FV works to relieve Seasonal Allergic
Rhinitis symptoms compared to Placebo (an inactive substance that looks like rBet v1-FV and
also contains Aluminum Hydroxide but does not contain the experimental drug). rBet v1-FV is a
vaccine that works by exposing your immune system to something that resembles birch. This
vaccine may help to lessen your allergy symptoms during the natural birch season.